Induction of the apoptosis of HL-60 promyelocytic leukemia cells by Eurya emarginata

Cancer Letters

Volumn 205, Issue 1, 2004, Pages 31-38

  Park, Soo Young ^a,b   Yang, Hong Chul ^b   Moon, Ji Young ^b   Lee, Nam Ho ^b   Kim, Se Jae ^b   Kang, Ji Hoon ^a   Lee, Young Ki ^a   Park, Deok Bae ^a   Yoo, Eun Sook ^a   Kang, Hee Kyoung ^a  

^a Jeju National University School of Medicine   (South Korea)

^b Jeju National University   (South Korea)

Author keywords

Apoptosis; Bax; Bcl 2; c Myc; Eurya emarginata; HL 60

Indexed keywords

ACETIC ACID ETHYL ESTER; DNA FRAGMENT; EURYA EMARGINATA EXTRACT; MESSENGER RNA; PLANT EXTRACT; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER GROWTH; CELL STRAIN HL 60; CONTROLLED STUDY; DIPLOIDY; DOWN REGULATION; EURYA EMARGINATA; HUMAN; HUMAN CELL; LEUKEMIA CELL; ONCOGENE C MYC; PLANT; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA;

EURYA; EURYA EMARGINATA;

EID: 1242293657     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2003.09.034     Document Type: Article

References (39)

1. Pezzuto J.M. Plant-derived anticancer agents. Biochem. Pharmacol. 24:1997;121-133.
2. Sporn M.B. Chemoprevention of cancer. Lancet. 343:1994;176-177.
3. Greenwald P., Nixon D.W., Malone W.F., Kelloff G.J., Stern H.R., Witkin K.M. Concepts in cancer chemoprevention research. Cancer. 65:1990;1483-1490.
4. Wattenberg L.W. Inhibition of carcinogenesis by minor dietary constituents. Cancer Res. 1:1992;2085-2091.
5. Park S.Y., Kang H.K. Effect of extracts of plants growing in Jeju on the growth of HL-60 cells. Cheju Journal of Life Science. 3:2000;85-94.
6. Chung M.G., Epperson B.K. Clonal and spatial genetic structure in Eurya emarginata (Theaceae). Heredity. 84:2000;170-177.
7. Carmichael J., DeGraff W.G., Gazdar A.F. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemisensitivity testing. Cancer Res. 47:1987;936-941.
8. Oberhammer F., Wilson J.W., Dive C., Morris I.D., Hickman J.A., Wakeling A.E., et al. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to in the absence of internucleasomal fragmentation. Eur. Mol. Biol. Org. J. 12:1993;3679-3684.
9. Sherwood S.W., Sheridan J.P., Atkinson R.C., Schimke R.T. Induction of apoptosis by the anti-tubline durg colcemid: Relationship of mitotic checkpoint control to the induction of apoptosis in HeLa S3 cells. Exp. Cell Res. 215:1994;373-379.
10. Wyllie A.H. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metastsis Rev. 11:1992;95-103.
11. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning Laboratory Manual. Second ed:1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. pp. 7-8.
12. Agarwal N., Mehta K. Possible involvement of Bcl-2 pathway in retinoid X receptor alpha-induced apoptosis of HL-60 cells. Biochem. Biophys. Res. Commun. 230:1997;251-253.
13. Watt R., Stanton L.W., Marcu K.B., Gallo R.C., Croce C.M., Rovera G. Nucleotide sequence of cloned cDNA of human c-myc oncogene. Nature. 303:1983;725-728.
14. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
15. Michael J.M., Lavin M.F., Watters D.J. Resistance to radiation-induced apoptosis in Burkitt's lymphoma cells is associated with defective ceramide signaling. Cancer Res. 57:1997;3600-3605.
16. Lehmann S., Bengtzen S., Paul A., Christensson B., Paul C. Effects of arsenic trioxide (As2O3) on leukemic cells from patients with non-M3 acute myelogenous leukemia: studies of cytotoxicity, apoptosis and the pattern of resistance. Eur. J. Haem. 66:2001;357-364.
17. Devireddy L.R., Teodoro J.G., Richard F.A., Green M.R. Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science. 293:2001;829-834.
18. Geller H.M., Cheng K.Y., Goldsmith N.K., Romero A.A., Zhang A.L., Morris E.J., Grandison L. Oxidative stress mediates neuronal DNA damage and apoptosis in response to cytosine arabinoside. J. Neurochem. 78:2001;265-275.
19. Mansat V., Bettaieb A., Levade T., Laurent G., Jaffrezou J.P. Serine protease inhibitors block neutral sphingomyelinase activation, ceramide generation, and apoptosis triggered by daunorubicin. Fed. Am. Soc. Exp. Biol. J. 11:1997;695-702.
20. Seo W.G., Pae H.O., Oh G.S., Chai K.Y., Yun Y.G., Chung H.T., et al. Ethyl acetate extract of the stem bark of Cudrania tricuspidata induces apoptosis in human leukemia HL-60 cells. Am. J. Chin. Med. 29:2001;313-320.
21. Bussing A., Stein G.M., Herterich-Akinpelu I., Pfuller U. Apoptosis-associated generation of reactive oxygen intermediates and release of pro-inflammatory cytokines in human lymphocytes and granulocytes by extracts from the seeds of Acalypha wilkesiana. J. Ethnopharmacol. 66:1999;301-309.
22. Yoon Y., Kim Y.O., Jeon W.K., Park H.J., Sung H.J. Tanshinone IIA isolated from Salvia miltiorrhiza BUNGE induced apoptosis in HL60 human premyelocytic leukemia cell line. J. Ethnopharmacol. 68:1999;121-127.
23. Iguchi-Ariga S.M., Itani T., Kiji Y., Ariga H. Possible function of the c-myc product: promotion of cellular DNA replication. Eur. Mol. Biol. Org. J. 6:1987;2365-2371.
24. Kato G.J., Dang C.V. Function of the c-Myc oncoprotein. Fed. Am. Soc. Exp. Biol. J. 6:1992;3065-3072.
25. Kimura S., Maekawa T., Hirakawa K., Murakami A., Abe T. Alterations of c-myc expression by antisense oligodeoxynucleotides enhance the induction of apoptosis in HL-60 cells. Cancer Res. 55:1995;1379-1384.
26. Hong S.H., Jeong S.Y., Ahn S.G., Hwang I.S., Kim I.K. Active adenosine transporter-mediated adenosine entrance into HL-60 cells leads to the induction of apoptosis through down-regulation of c-Myc. Exp. Mol. Med. 29:1997;183-190.
27. Thompson E.B. The many roles of c-Myc in apoptosis. Annu. Rev. Physiol. 60:1998;575-600.
28. Prendergast G.C. Mechanisms of apoptosis by c-Myc. Oncogene. 18:1999;2967-2987.
29. 2+ pool depletion. Oncogene. 12:1996;2051-2055.
30. Shimizu T., Pommier Y., fragmentation D.N.A. induced by protease activation in p53-null human leukemia HL60 cells undergoing apoptosis following treatment with the topoisomerase I inhibitor Campotothecin: Cell-free system studies. Exp. Cell Res. 226:1996;292-301.
31. Chiou S.K., Rao L., White E. Bcl-2 blocks p53-dependent apoptosis. Mol. Cell Biol. 14:1994;2556-2563.
32. Dole M., Nunez G., Merchant A.K., Maybaum J., Rode C.K., Bloch C.A., Castle V.P. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res. 54:1994;3253-3259.
33. Baff G., Miyashita T., Williamson J.R., Reed J.C. Apoptosis induced by withdrawal of interleukin-3(IL-3) from an IL-3-dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production. J. Biol. Chem. 268:1993;6511-6519.
34. Oltvai Z.N., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 79:1994;189-192.
35. Hanada M., Krajewski S., Tanaka S., Cazals-Hatem D., Spengler B.A., Ross R.A., et al. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells. Cancer Res. 53:1993;4978-4986.
36. Miyashita T., Reed J.C. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood. 81:1993;151-157.
37. Campos L., Sabiolo J.P., Oriol P., Roubi N., Vasselan C., Archimbaud E. High expression of bcl-2 protein in acute myeloid leukemia cells associated with poor response to chemotherapy. Blood. 81:1993;3091-3096.
38. Kohler C., Orrenius S., Zhivtovaky B. Evaluation of caspase in apoptotic cell. J. Immunol. Methods. 265:2002;97-110.
39. Nicholson D.W., Thornberry N.A. Caspase: killer proteases. Trends Biochem. Sci. 22:1997;299-306.